Search by Drug Name or NDC
NDC 42023-0196-25 Corphedra 50 mg/mL Details
Corphedra 50 mg/mL
Corphedra is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Par Pharmaceutical, Inc.. The primary component is EPHEDRINE SULFATE.
Product Information
| NDC | 42023-0196 |
|---|---|
| Product ID | 42023-196_aa6213f5-e549-4e42-a795-b791de8353b7 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Corphedra |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Ephedrine Sulfate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 50 |
| Active Ingredient Units | mg/mL |
| Substance Name | EPHEDRINE SULFATE |
| Labeler Name | Par Pharmaceutical, Inc. |
| Pharmaceutical Class | Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Increased Norepinephrine Activity [PE], Norepinephrine Releasing Agent [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA208943 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 42023-0196-25 (42023019625)
| NDC Package Code | 42023-196-25 |
|---|---|
| Billing NDC | 42023019625 |
| Package | 25 VIAL in 1 CARTON (42023-196-25) / 1 mL in 1 VIAL (42023-196-01) |
| Marketing Start Date | 2017-02-16 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |